125 related articles for article (PubMed ID: 606416)
1. Treatment of patients with senile, post-menopausal and corticosteroid-induced osteoporosis with 1alpha-hydroxyvitamin D3 and calcium: short- and long-term effects.
Lindholm TS; Sevastikoglou JA; Lindgren U
Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():183s-189s. PubMed ID: 606416
[No Abstract] [Full Text] [Related]
2. Short-term effects of 1-alpha-hydroxy-vitamin D3 in patients on corticosteroid treatment and in patients with senile osteoporosis.
Lindgren U; Lindholm S; Sarby B
Acta Med Scand; 1978; 204(1-2):89-92. PubMed ID: 685736
[TBL] [Abstract][Full Text] [Related]
3. Preventive treatment of osteoporosis with 1 alpha-hydroxyvitamin D3 and calcium. Evaluation of bone histomorphometry in osteoporotics and age matched controls.
Lindholm TS; Nilsson OS; Widhe T; Elmsted E; Eriksson S
Acta Vitaminol Enzymol; 1982; 4(1-2):179-84. PubMed ID: 7124565
[No Abstract] [Full Text] [Related]
4. Bone mineral and calcium metabolism before, during and after treatment of osteoporosis with 1 alpha-hydroxyvitamin D3 and calcium.
Lindholm TS; Eriksson S
Scand J Rheumatol; 1982; 11(1):55-7. PubMed ID: 7063813
[TBL] [Abstract][Full Text] [Related]
5. Treatment of senile osteoporosis with 1alpha-hydroxyvitamin D3.
Sørensen OH; Andersen RB; Christensen MS; Friis T; Hjorth L; Jørgensen FS; Lund B; Melsen F; Mosekilde L
Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():169s-175s. PubMed ID: 342143
[TBL] [Abstract][Full Text] [Related]
6. Results of long-term treatment of osteoporosis with 1 alpha-hydroxyvitamin D3 and calcium.
Lindholm TS; Eriksson S; Lindholm TC
Ital J Orthop Traumatol; 1984 Jun; 10(2):187-201. PubMed ID: 6432736
[TBL] [Abstract][Full Text] [Related]
7. The effect of 1alpha-hydroxyvitamin D3 with and without oestrogens on calcium balance in post-menopausal women.
Marshall DH; Nordin BE
Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():159s-168s. PubMed ID: 606414
[TBL] [Abstract][Full Text] [Related]
8. Changes in bone histomorphometry and bone mineral during treatment of osteoporosis with 1 alpha-hydroxyvitamin D3 and calcium.
Lindholm TS; Nilsson OS; Elmstedt E; Eriksson SA; Lindholm TC; Kyhle BR
Acta Vitaminol Enzymol; 1981; 3(3):170-6. PubMed ID: 7347489
[TBL] [Abstract][Full Text] [Related]
9. Short-term effects of varying doses of 1 alpha-hydroxyvitamin D3 on blood and urine chemistry and calcium absorption of osteoporotic patients.
Lindholm TS; Sevastikoglou JA; Lindgren U
Clin Orthop Relat Res; 1978 Sep; (135):226-31. PubMed ID: 709935
[TBL] [Abstract][Full Text] [Related]
10. The effect of 1alpha-hydroxycholecalciferol and hormone therapy on the calcium balance of post-menopausal osteoporosis.
Marshall DH; Gallagher JC; Guha P; Hanes F; Oldfield W; Nordin BE
Calcif Tissue Res; 1977 May; 22 Suppl():78-84. PubMed ID: 334349
[No Abstract] [Full Text] [Related]
11. Effects of 1,25-dihydroxycholecalciferol on 47calcium absorption in post-menopausal osteoporosis.
Caniggia A; Vattimo A
Clin Endocrinol (Oxf); 1979 Jul; 11(1):99-103. PubMed ID: 519874
[TBL] [Abstract][Full Text] [Related]
12. A low dose regime of 1 alpha hydroxyvitamin D3 in the management of senile osteoporosis: a pilot study.
Cohen HN; Farrah D; Fogelman I; Goll CC; Beastall GH; McIntosh WB; Fletcher M; Boyle IT
Clin Endocrinol (Oxf); 1980 Jun; 12(6):537-42. PubMed ID: 7398099
[TBL] [Abstract][Full Text] [Related]
13. Bone mineral content, cortical thickness and fracture rate in osteoporotic women after withdrawal of treatment with nandrolone decanoate, 1-alpha hydroxyvitamin D3, or intermittent calcium infusions.
Geusens P; Dequeker J; Verstraeten A; Nijs J; Van Holsbeeck M
Maturitas; 1986 Dec; 8(4):281-9. PubMed ID: 3574141
[TBL] [Abstract][Full Text] [Related]
14. Prevalence, pathogenesis and treatment of post-menopausal osteoporosis.
Crilly R; Horsman A; Marshall DH; Nordin BE
Aust N Z J Med; 1979 Feb; 9(1):24-30. PubMed ID: 313208
[TBL] [Abstract][Full Text] [Related]
15. Osteopenia in rheumatology practice: pathogenesis and therapy.
Tannenbaum H
Semin Arthritis Rheum; 1984 May; 13(4):337-48. PubMed ID: 6374899
[TBL] [Abstract][Full Text] [Related]
16. Corticosteroid-induced osteopenia.
Hahn TJ
Arch Intern Med; 1978 May; 138 Spec No():882-5. PubMed ID: 646579
[No Abstract] [Full Text] [Related]
17. Interim report on treatment of osteoporotic patients with 1 alpha-hydroxyvitamin D3 and calcium.
Lindholm TS; Sevastikoglou JA; Lindgren U
Clin Orthop Relat Res; 1978 Sep; (135):232-40. PubMed ID: 709936
[TBL] [Abstract][Full Text] [Related]
18. Treatment of osteoporosis with 1-alpha-hydroxycholecalciferol and calcium.
Hoikka V; Alhava EM; Aro A; Karjalainen P; Rehnberg V
Acta Med Scand; 1980; 207(3):221-4. PubMed ID: 6989171
[TBL] [Abstract][Full Text] [Related]
19. Comparison of therapeutic usefulness of vitamin D3 analogs on osteoporosis caused by ovariectomy in rats.
Izawa Y; Sagara K; Kadota T; Makita T
Acta Vitaminol Enzymol; 1985; 7(3-4):173-81. PubMed ID: 3841463
[TBL] [Abstract][Full Text] [Related]
20. 1alpha-hydroxyvitamin D2 is less toxic but not bone selective relative to 1alpha-hydroxyvitamin D3 in ovariectomized rats.
Weber K; Goldberg M; Stangassinger M; Erben RG
J Bone Miner Res; 2001 Apr; 16(4):639-51. PubMed ID: 11315991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
